How should phase II trials in cardiovascular medicine be conducted?
Publication
, Journal Article
Califf, R
Published in: American Heart Journal
January 1, 2000
Duke Scholars
Published In
American Heart Journal
DOI
ISSN
0002-8703
Publication Date
January 1, 2000
Volume
139
Issue
4
Start / End Page
S131 / S132
Related Subject Headings
- Cardiovascular System & Hematology
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Califf, R. (2000). How should phase II trials in cardiovascular medicine be conducted? American Heart Journal, 139(4), S131–S132. https://doi.org/10.1016/s0002-8703(00)90059-0
Califf, R. “How should phase II trials in cardiovascular medicine be conducted?” American Heart Journal 139, no. 4 (January 1, 2000): S131–32. https://doi.org/10.1016/s0002-8703(00)90059-0.
Califf R. How should phase II trials in cardiovascular medicine be conducted? American Heart Journal. 2000 Jan 1;139(4):S131–2.
Califf, R. “How should phase II trials in cardiovascular medicine be conducted?” American Heart Journal, vol. 139, no. 4, Jan. 2000, pp. S131–32. Scopus, doi:10.1016/s0002-8703(00)90059-0.
Califf R. How should phase II trials in cardiovascular medicine be conducted? American Heart Journal. 2000 Jan 1;139(4):S131–S132.
Published In
American Heart Journal
DOI
ISSN
0002-8703
Publication Date
January 1, 2000
Volume
139
Issue
4
Start / End Page
S131 / S132
Related Subject Headings
- Cardiovascular System & Hematology
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1102 Cardiorespiratory Medicine and Haematology